No Pharma Money
All News & Reports

News

The week in prescription drug pricing: what moved, what it means for patients, and what comes next.

Stay Up To Date

News and reports from P4ADNow

News Oct 28, 2022

The Week in Review in Prescription Drug Pricing

Thanks to the Inflation Reduction Act, millions of patients won’t get Tricked by Big Pharma, only Treated to lower drug prices?

Read Article
News Oct 22, 2022

The Week in Review in Prescription Drug Pricing

A new study found that in 2021, almost 1 in 5 U.S adults with diabetes skipped, delayed, or used less of their insulin due to the high price.

Read Article
News Oct 15, 2022

The Week in Review in Prescription Drug Pricing

Patients are drawing a line in the sand, pushing back hard on Republican Senators Lankford (OK), Lee (UT), Lummis (WY), and Rubio (FL)’s recent effort to force them to pay more for their prescriptions.

Read Article
News Oct 13, 2022

Patients Denounce Senator Lummis’ Effort To Repeal Reforms That Lower Prescription Drug Prices And Reduce Out-Of-Pocket Costs

Patients are pushing back hard on Senator Cynthia Lummis’ recent effort to force them to pay more for their prescriptions.

Read Article
News Oct 13, 2022

Patients Denounce Senator Lankford’s Effort To Repeal Reforms That Lower Prescription Drug Prices And Reduce Out-Of-Pocket Costs

“Our Senators Should Be Working To Expand These Reforms To All Americans, Not Reverse Them. This Legislation Is Unforgivable.”

Read Article
News Oct 13, 2022

Patients Denounce Senator Rubio’s Effort To Repeal Reforms That Lower Prescription Drug Prices And Reduce Out-Of-Pocket Costs

“Finally, Congress Passed A Law To Allow Medicare To Negotiate Drug Prices, And Senator Rubio Wants To Reverse It?!

Read Article
News Oct 13, 2022

Patients Denounce Senator Lee’s Effort To Repeal Reforms That Lower Prescription Drug Prices And Reduce Out-Of-Pocket Costs

“I’m Furious That Senator Lee Spews Big Pharma Lies While He Tries To Make Sure Drug Companies Can Continue To Price Gouge Me For My Prescriptions.”

Read Article
News Oct 13, 2022

Patients Denounce Republican Senators’ Effort To Repeal Reforms That Lower Prescription Drug Prices And Reduce Out-Of-Pocket Costs

“I’m Furious That Senator Lee Spews Big Pharma Lies While He Tries To Make Sure Drug Companies Can Continue To Price Gouge Me For My Prescriptions.”

Read Article
News Oct 8, 2022

The Week in Review in Prescription Drug Pricing

Last week, the Food and Drug Administration approved Relyvrio, a drug combination to treat amyotrophic lateral sclerosis (ALS), a progressive and fatal disease of the nervous system that affects tens…

Read Article
News Sep 30, 2022

The Week in Review in Prescription Drug Pricing

2023 is looking brighter than ever between Rihanna at the Superbowl and the $35 insulin copay caps for Medicare beneficiaries.

Read Article

Stay Connected

Stay informed about the latest campaigns, policy developments, and ways to help lower prescription drug prices.